UPDATE -- OXiGENE Announces Positive Topline Results From Randomized Phase 2 Study GOG186I of ZYBRESTAT(R) in Combination With Avastin(R) for Recurrent Ovarian Cancer
Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries | Pharmaceuticals | Study